Articles in section Licensing
| << Joint Venture | 441 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 45 | Next >> |
-
Boehringer Ingelheim Buys Rights to Enleofen’s Fibro-inflammatory Anti-IL-11 Platform
-
Roche Licenses Sarepta’s DMD Therapy for US$2.88 B
-
Jazz Pharmaceuticals Licenses PharmaMar’s Lung Cancer Drug Lurbinectedin
-
Allergan Continues to Grow Medical Aesthetics Franchise with Exicure Deal
-
Ipsen Boosts Rare Disease Portfolio with Blueprint’s BLU-782
-
Takeda Bolsters IBD Pipeline by Partnering with Prometheus Biosciences
-
Boehringer Ingelheim Targets KRAS Mutations with Lupin’s LNP3794
-
Pfizer Licenses Akcea’s AKCEA-ANGPTL3-LRx
-
Astellas Licenses RIKEN’s aAVC Cell Therapy Technology for US$9.4 M Upfront
-
Celgene Fortifies Immuno-oncology Presence with Immatics Alliance
RSS